- March 15, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
boniva
Synonyms :
Class :
Calcium metabolism modifiers, Biphosphonate derivative
Dosage Forms & Strengths
Tablet:150mg
Prefilled syringe:1mg/1ml
150
mg
Orally
once a month
Tablet
IV:3 mg every 3 months
gilteritinib may enhance the QTc-prolonging effect of QT-prolonging Agents
may enhance the QTc-prolonging effect of QT-prolonging agents
may enhance the QTc-prolonging effect of QT-prolonging agents
may enhance the QTc-prolonging effect of QT-prolonging agents
may enhance the QTc-prolonging effect of QT-prolonging agents
may enhance the QTc-prolonging effect of QT-prolonging agents
may diminish the serum concentration of polyvalent cation-containing products
may increase the QTc prolonging effect
may increase the QTc prolonging effect
may have an increased QTc-prolonging effect when combined with amisulpride (oral)
may increase the QTc prolonging effect of QT-prolonging agents
may have an increased QTc-prolonging effect when combined with amiodarone
may have an increased QTc-prolonging effect when combined with delamanid
may diminish the serum concentration of Polyvalent Cation Containing Products
aluminum hydroxide/magnesium carbonate
may decrease the serum concentration of Polyvalent Cation Containing Products
may decrease the serum concentration of Polyvalent Cation Containing Products
dasatinib: they may increase the QTc-prolonging effect of QTc-prolonging Agents
encorafenib: they may increase the QTc-prolonging effect of QTc-prolonging agents
etelcalcetide: they may increase the QTc-prolonging effect of QTc-prolonging agents
flecainide: they may increase the QTc-prolonging effect of QTc-prolonging Agents
fluconazole: they may increase the QTc-prolonging effect of QTc-prolonging agents
methadone: they may increase the QTc-prolonging effect of QTc -prolonging agents
sunitinib: they may increase the QTc-prolonging effect of QTc-prolonging Agents
may increase the QTc-prolonging effect of each other when combined
may increase the QTc-prolonging effect of each other when combined
may increase the QTc-prolonging effect of each other when combined
may increase the QTc-prolonging effect of each other when combined
may increase the QTc-prolonging effect of each other when combined
it may enhance the QTc-prolonging effect of terfenadine
may diminish the serum concentration of polyvalent cation-containing products
may have an increased QTc-prolonging effect when combined with QT-prolonging agents
may have an increased QTc-prolonging effect when combined with QT-prolonging agents
may have an increased QTc-prolonging effect when combined with pazopanib
may have an increased QTc-prolonging effect when combined with QT-prolonging agents
clarithromycin: they may increase the QTc-prolonging effect of QTc-prolonging Agents
levoketoconazole: they may increase the QTc-prolonging effect of QTc-prolonging Agents
probucol: they may increase the QTc-prolonging effect of QTc-prolonging Agents
sparfloxacin: they may increase the QTc-prolonging effect of QTc-prolonging Agents
angiogenesis Inhibitors may enhance the adverse/toxic effect of bisphosphonate derivatives
angiogenesis Inhibitors may enhance the adverse/toxic effect of bisphosphonate derivatives